170231 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; DNA viruses Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC COMPLEXES
#2Human Papillomavirus Multiplex Serology Assay
#3BK VIRUS NEUTRALIZING ANTIBODIES
#4BK VIRUS NEUTRALIZING ANTIBODIES
#5METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST
#6COLLECTION DEVICE FOR DIAGNOSTICS OF VAGINAL DISCHARGE
#7METHODS AND USES OF CRISPR CASCADE REACTIONS FOR CRISPR DIAGNOSTICS
#8Peptides and combinations of peptides for use in immunotherapy against oropharyngeal squamous cell carcinoma (OPSCC) and other cancers
#9METHOD OF ASSESSING RISK OF PML
#10METHODS AND SYSTEMS FOR DETECTING HUMAN PAPILLOMAVIRUSES (HPV) IN BIOLOGICAL SAMPLES
#11METHOD OF ASSESSING RISK OF PML
#12SCREENING SYSTEMS AND METHODS FOR HPV-ASSOCIATED CERVICAL DISEASE
#13METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#14METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
#15BINDING PROTEINS RECOGNIZING HPV16 E7 ANTIGEN AND USES THEREOF
#16Methods for assessing risk of developing a viral disease using a genetic test
#17CRISPR ASSAY FOR RAPID, ENHANCED SCREENING OF HPV-RELATED DISEASE
#18MULTIPLEXED LATERAL FLOW ASSAY FOR DETECTION OF HPV ASSOCIATED CANCER
#19Assay for detecting human papilloma virus (HPV)
#20NEW ANTIBODY TARGETING THE VP-1 PROTEIN, FRAGMENTS THEREOF, AND USES OF SAME FOR DETECTING INFECTION WITH THE BK POLYOMAVIRUS
#21METHODS AND COMPOSITIONS FOR DIRECT CHEMICAL LYSIS
#22ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
#23Method of assessing risk of PML
#24Nucleic acid probe set and nucleic acid lateral flow immunoassay having the same
#25COMPOSITIONS AND METHODS FOR URINE SAMPLE STORAGE AND DNA EXTRACTION
#26SCREENING SYSTEMS AND METHODS FOR HPV-ASSOCIATED CERVICAL DISEASE
#27Method of assessing risk of PML
#28Multi-level specific targeting of cancer cells
#29METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST
#30COLLECTION DEVICE FOR DIAGNOSTICS OF VAGINAL DISCHARGE
#31Anti-human papillomavirus 16 E7 T cell receptors
#32Functionalized DNA Dendrimers For Gene Delivery To Cells
#33Method of assessing risk of PML
#34Serologic test for therapy control of HPV16 positive carcinoma
#35Compositions and methods for detection of BK virus
#36Kits and methods for pathogen detection
#37Assay for detecting human papilloma virus (HPV)
#38Point-of-Care Fluorescent Immunoassay for Identifying Biomarkers in Patient Biofluid Samples
#39METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
#40BIOMARKERS AND PATIENT SELECTION STRATEGIES
#41Multi-level specific targeting of cancer cells
#42Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#43Methods for assessing risk of developing a viral disease using a genetic test
#44Methods for assessing risk of developing a viral disease using a genetic test
#45Methods of treating inflammatory and autoimmune diseases with natalizumab
#46Papillomavirus pseudoviruses for detection and therapy of tumors
#47Methods and devices for detection of pathogens
#48Methods and compositions for direct chemical lysis
#49Methods of treating a multiple sclerosis patient with anti-VLA-4 therapy
#50Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#51Multi-level specific targeting of cancer cells
#52Method of assessing risk of PML
#53Serologic test for therapy control of HPV16 positive carcinoma
#54BK VIRUS SEROLOGY ASSESSMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) RISK
#55Collection device for diagnostics of vaginal discharge
#56Anti-human papillomavirus 16 E7 T cell receptors
#57Method for the normalization of immunological tests and kits for performing such tests
#58PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS
#59Rapid test for the qualitative and/or quantitative analysis of antibodies against human papilloma viruses (HPV) present in body fluid, and device for carrying out the rapid test
#60IMMUNOLOGICAL TEST FOR THE DETECTION OF E7 ONCOPROTEINS IN BIOLOGICAL SAMPLES
#61Methods for assessing risk of developing a viral disease using a genetic test
#62Method of treating cervical neoplasia in patients infected with human papilloma virus
#63Point-of-care fluorescent immunoassay for identifying biomarkers in patient biofluid samples
#64ASSAY
#65Assay system to identify HPV replication inhibitors in HT-screen
#66Next-Generation Sequencing-Based Genotyping Assay for Human Papilloma Virus (HPV)
#67Compositions and methods for detection of BK virus
#68Peptide, antibody thereof, and method of assessing risk of oral cancer by using peptide
#69Kits and methods for pathogen detection
#70Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#71Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
#72METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY
#73Cervical cancer-related HPV E7 protein monoclonal antibody and use thereof
#74Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#75Methods of treating inflammatory and autoimmune diseases with natalizumab
#76BIOSENSORS FOR THE DETECTION OF INFECTION AND ASSOCIATED MALADIES
#77HPV16 Antibodies as Diagnostic and Prognostic Biomarkers in Pre-Invasive and Invasive Disease
#78Apparatus for detecting cells being infected with human papillomavirus (HPV) and a detection method therefor
#79Anti-human papillomavirus 16 E7 T cell receptors
#80METHOD FOR DETECTING CARCINOGENESIS IN THE UTERINE CERVIX
#81Rapid test for the qualitative and/or quantitative analysis of antibodies against human papilloma viruses (HPV) present in body fluid, and device for carrying out the rapid test
#82Identification of JC viral epitopes by cytotoxic T lymphocytes in healthy individuals and their use in assays
#83NOVEL METHODS, BIOASSAYS, AND BIOMARKERS FOR HPV-RELATED CONDITIONS
#84Method of treating cancer using immune checkpoint inhibitor
#85Method of assessing risk of PML
#86Immunogenic JC polyomavirus compositions and methods of use
#87Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
#88Anti-HPV E7 antibodies
#89Method of efficient extraction of protein from cells
#90Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#91Methods and compositions for direct chemical lysis
#92Assay for JC virus antibodies
#93Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus E6 protein
#94Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same
#95Method of assessing risk of PML
#96Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#97Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#98Functionalized DNA Dendrimers For Gene Delivery To Cells
#99Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy
#100Method of protein extraction from cells
#101Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
#102Methods for the detection of JC polyoma virus
#103Multi-level specific targeting of cancer cells
#104Papillomavirus pseudoviruses for detection and therapy of tumors
#105ANTIBODIES SPECIFIC TO E6 PROTEINS OF HPV AND USE THEREOF
#106In situ detection of early stages and late stages HPV infection
#107Antibodies for oncogenic strains of HPV and methods of their use
#108POLYOMAVIRUS PEPTIDE SEQUENCES
#109Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#110Method for detecting polyomavirus reactivation
#111METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS AND PROVIDING PROGNOSIS FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA
#112Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#113Truncated L1 protein of human papillomavirus type 6
#114Methods and compositions for inhibiting polyomavirus-associated pathology
#115Sample processing method using tube strips and tube strip holder
#116Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same
#117Rapid test for the qualitative and/or quantitative analysis of antibodies against Human Papilloma Viruses (HPV) present in body fluid, and device for carrying out the rapid test
#118Papillomavirus pseudoviruses for detection and therapy of tumors
#119METHODS FOR THE DETECTION OF JC POLYOMA VIRUS
#120Anti-HPV E7 antibodies
#121Assay for JC virus antibodies
#122DETECTION OF EARLY STAGES AND LATE STAGES HPV INFECTION
#123High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers
#124AUTOMATED PAP SCREENING USING A PLURALITY OF BIOMARKERS AND MULTI-SPECTRAL IMAGING
#125METHODS FOR THE DETECTION OF JC POLYOMA VIRUS
#126Gene Expression Biomarkers in PAP Test Material for Assessing HPV Presence and Persistence
#127Antibodies For Oncogenic Strains Of HPV And Methods Of Their Use
#128ANTIBODIES SPECIFIC TO E6 PROTEINS OF HPV AND USE THEREOF
#129Immunological method for detecting active JCV infection
#130Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#131Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
#132METHODS OF DIAGNOSING CERVICAL CANCER
#133Multi-level specific targeting of cancer cells with IL-13
#134HPV E6 protein T cell epitopes and uses thereof
#135Biomarkers for the detection of head and neck tumors
#136Peptides for inhibiting the HPV-E6 oncoprotein
#137Method and compositions for inhibition of double stranded DNA viruses
#138Compounds For Treating Human Papillomavirus
#139Protein Chips for HPV Detection
#140MARKER FOR ESTIMATING THE DIAGNOSIS OF CERVICAL ADENOCARCINOMA OR FOR ESTIMATING THE PROGNOSIS OF CERVICAL CANCER
#141Compositions and Methods to Inhibit HPV Infection
#142COMBINATION THERAPY
#143Methods and compositions for direct chemical lysis
#144DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#145METHOD FOR THE IN VITRO DIAGNOSIS AND/OR IN VITRO THERAPY MONITORING OF INFECTIONS
#146Truncated L1 protein of human papillomavirus type 6
#147HIGH SENSITIVITY NANOTECHNOLOGY-BASED MULTIPLEXED BIOASSAY METHOD AND DEVICE
#148Antibodies for oncogenic strains of HPV and methods of their use
#149Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof
#150Methods of treating inflammatory and autoimmune diseases with natalizumab
#151Papillomavirus pseudoviruses for detection and therapy of tumors
#152METHODS AND COMPOSITIONS FOR TREATING CERVICAL CANCER
#153Detection, screening, and diagnosis of HPV-associated cancers
#154Detection of early stages and late stages HPV infection
#155IN SITU detection of early stages and late stages HPV infection
#156Monoclonal antibodies against HPV proteins
#157In situ detection of early stages and late stages HPV infection
#158Methods for diagnosing oncogenic human papillomavirus (HPV)
#159METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE
#160HPV E6 protein T cell epitopes and uses thereof
#161Method of efficient extraction of protein from cells
#162Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#163Advanced cervical cell screening methods
#164METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE
#165Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
#166Antibodies for oncogenic strains of HPV and methods of their use
#167DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#168Protein chips for HPV detection
#169Methods of diagnosing cervical cancer
#170Method of protein extraction from cells
#171Methods of treating inflammatory and autoimmune diseases with natalizumab
#172Combination of anti-hpv-16 and 18 antibodies and uses thereof
#173Human papilloma virus immunoreactive peptides
#174Systems of diagnosing cervical cancer
#175High affinity probes for analysis of human papillomavirus expression
#176Methods and compositions for treating cervical cancer
#177Cd4+ human papillomavirus (hpv) epitopes
#178Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15
#179Methods and compositions for the detection of cervical disease
#180Methods and compositions for the detection of cervical disease
#181Methods of collecting and transporting vaginal discharge for detection of infectious organisms and to facilitate cervical cancer screening
#182Peptides from the E2 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers
#183E7 regulation of p21 cip1 through akt
#184Tr4/tr2 response elements
#185Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
#186Regions of papilloma virus E1 helicase involved in E1 oligomerization
#187Methods and compositions for the detection of cervical disease
#188Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#189Methods of diagnosing cervical cancer
#190Compounds for treating human papillomavirus
#191Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers
#192Human papillomavirus multiplexed assay
#193Antibodies for oncogenic strains of HPV and methods of their use
#194Human papillomavirus inhibitors
#195Complexes and methods of using same
#196Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
#197Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16
#198Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16
#199Methods for determining risk of developing cervical cancer
#200Method for detecting pathogenic agents